<DOC>
	<DOC>NCT00938847</DOC>
	<brief_summary>Evaluative pilot study for safety and feasibility with administration of autologous bone bone marrow derived mononuclear cells by endoventricular catheter into the normal border zone fo the ischemic lesion.</brief_summary>
	<brief_title>Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration</brief_title>
	<detailed_description />
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction, Left</mesh_term>
	<criteria>LVEF &lt;40% PCI at latest 6 hours after infarction BMI &gt;20 kg/m² and &lt;30 kg/m² PCI elder than 14 days relevant valvular disease left ventricular dysfunction caused by other reasons than ischemic cardiomyopathy history of stroke, chronic atrial fibrillation, multivessel disease, thromboembolic event scheduled for CABG DM Type 1 &amp; extensive hypercholesterinemia pacemaker systemic disease Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>left ventricular dysfunction</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>left ventricular dysfunction (LVDF) after acute myocardial infarction</keyword>
</DOC>